je.st
news
Home
›
OncoMed Pharmaceuticals CEO Testifies on Behalf of BIO at Congressional Hearing on FDA Drug ...
OncoMed Pharmaceuticals CEO Testifies on Behalf of BIO at Congressional Hearing on FDA Drug ...
2013-12-12 06:00:00| Industrial Newsroom - All News for Today
House Committee on Oversight & Government Reform, Subcommittee on Energy Policy, Health Care & Entitlements held a hearing entitled, "FDA Check-Up: Drug Development and Manufacturing Challenges." Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals and Chairman of BIO’s Emerging Companies Section Governing Board, presented testimony emphasizing the positive indicators that demonstrate the biopharma industry is rebounding, but significant financial and regulatory challenges ...This story is related to the following:Green & CleanSearch for suppliers of:
Tags: on
drug
behalf
bio
Category:Industrial Goods and Services
Latest from this category |
All news |
||||||||||||||||||||||
|
|
||||||||||||||||||||||